Skip to main content
Publications
Hsu RK, Phoenix J, Sinclair GI, Gupta SK, Puga A, Nguyen K, Schubert CK, Merrill D, Richardson D , Nelson K , Reynolds M , Zografos L , Jean-Louis A, Garris C. US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND) . Poster presented at the IDWeek 2022 Conference; October 21, 2022. Washington, DC.
Armstrong A, Jayade S, Rege S, Joshi N, Patel V, Davidson D, Kalirai S, Wolin D , Boyle K , Patel D, Seigel L. Evaluating treatment choice among patients with moderate or severe psoriasis . Poster presented at the 2022 Fall Clincial Dermotology Conference; October 20, 2022. Las Vegas, NV.
Bhatia S, Nghiem P, Veeranki SP, Vanegas A , Lachance K, Tachiki L, Chiu K, Boller E, Bharmal M. Real-world clinical outcomes among patients with advanced Merkel cell carcinoma treated with avelumab in academic medical centers in the United States . Presented at the 2022 2nd International Symposium on Merkel Cell Carcinoma; April 25, 2022. Seattle, WA. Previously presented at the SITC 2021 36th Anniversary Annual Meeting.
Prabhu V, Kelkar S, Corman S, Macahilig C, Rusibamayila N, Odak S , Duska L. Treatment patterns, real-world outcomes, and resource use in patients with non-MSI-high or mismatch repair proficient advanced endometrial cancer . Poster presented at the 2022 Virtual Hem/Onc Pharmacists Assoc (HOPA) Annual Conference; March 30, 2022. Boston, MA.